Lingohr & Partner Asset Management Gmb H Biogen Inc. Transaction History

Lingohr & Partner Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $673,469 - $854,305	-2,505 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $153,503 - $169,204	700 Added 38.78%	2,505 $586,000
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $391,161 - $611,822	1,805 New	1,805 $427,000
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $979,348 - $1.17 Million	-3,803 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$260.13 - $367.91 $168,564 - $238,405	648 Added 20.54%	3,803 $1.04 Million
Q4 2017 Jan 19, 2018	SELL	$307.64 - $344.58 $18,150 - $20,330	-59 Reduced 1.84%	3,155 $1.01 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $903,616 - $1.06 Million	3,214	3,214 $1.02 Million

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.